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PURPOSE: The aim of this investigation was to quantitatively evaluate C-cells in colloid goiters, analyzing 36
thyroids that were obtained through thyroidectomy from 24 patients with goiter and 12 normal glands from adult patients
without thyroid disease, which were used as the control group.
MATERIAL AND METHODS: On average, 6 different thyroid areas were sampled and labeled by
immunohistochemistry with a monoclonal anticalcitonin antibody, utilizing the avidin-biotin-peroxidase complex. C-
cells were counted in fields measuring 1 square centimeter, and the mean number of cells per field was then calculated. Data
were statistically analyzed using the Mann-Whitney test.
RESULTS: In the colloid goiter group, the number of C-cells ranged from 0 to 23 per field, while in normal controls
they ranged from 20 to 148 per field.
CONCLUSIONS: These results demonstrate a significant decrease of C-cell number in the colloid goiter group compared
with control group, indicating that the hyperplastic process is restricted to follicular cells, to the detriment of C-cells, which
probably cease to receive trophic stimuli.
DESCRIPTORS: C-cells. Thyroid. Colloid goiter. Calcitonin.
Colloid goiter is a hyperplastic dis-
ease of thyroid follicular cells due to
multifactorial causes. One of the most
accepted and well-documented hy-
potheses of etiology is a reduced pro-
duction of thyroid hormone and con-
sequent increased level of thyroid
stimulant hormone (TSH), which ini-
tially causes gland hyperplasia, fol-
lowed by the development of multiple
monoclonal adenomas1-3. In multin-
odular goiters, each individual nodule
may respond in a diverse way under
TSH influence and, as a physiologic
structure, is dependent on genetic char-
acteristics inherited from the stem
cells4. Among the causal factors of col-
loid goiter, foods that block the hor-
monal synthesis, mutations in TSH
receptors, iodine-poor diets, globulin
stimulation of thyroid development,
growth hormone (GH), insulin-like
growth factor (IGF-1), and genetic fac-
tors are implicated3.
In addition to follicular cells, in the
thyroid gland there are C-cells, which
are producers of calcitonin, an impor-
tant hormone acting on calcium
homeostasis5. These cells are heteroge-
neously distributed in the gland, with
higher concentrations in the medial and
superior thirds of the thyroid lateral
lobe, and they are scanty in the isth-
mus6,7. Immunohistochemical and ul-
trastructural studies have shown that C-
cells occupy, exclusively, intrafollicular
sites and are separated from the inter-
stitium by follicular basal lamina8, 9.
The possible influence upon C-
cells of thyroid hormones and other
factors that control thyroid function
such as iodine remains controversial10.
Several studies indicate that TSH and
TSH-releasing hormone (TRH) also
participate in C-cell regulation 10.
Some authors have found mRNA for
TSH and TRH receptors, as well as for
thyroglobulin and thyroperoxidase in
C-cells11. Moreover, other studies
showed that high levels of TRH would
deliver calcitonin in these cells, simi-
lar to the effect of pentagastrin12. These
data seem to indicate some interac-
tions between thyroid follicular cells
and C-cells with respect to delivering
thyroid hormone and calcium metabo-
lism, which merit further investigation.
In addition to these functional as-
pects, it has been shown that high lev-
els of TSH may cause C-cell hyperpla-
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sia13,14. Moreover, quantitative changes
in C-cells may occur in conditions
such as familial hyperplasia associated
with multiple endocrine neoplasia and
Hashimoto’s chronic thyroiditis15,16.
Nevertheless, quantitative studies of C-
cells in colloid goiter are scanty.
Inoue, in 199017, observed through a
histochemistry method a reduced
number of C-cells in colloid goiters,
when compared to normal thyroids.
The aim of this study was to quan-
tify C-cells in colloid goiters to evalu-
ate a possible role of these cells in the
pathogenesis of goiters.
MATERIALS AND METHODS
Case selection. Thyroid samples
obtained from patients with colloid
goiters who underwent thyroidectomy
were systematically studied in the
Pathologic Anatomy Laboratory from
the Association of Combat of Cancer
from Central Brazil (ACCCB), in the
city of Uberaba In addition to esthetic
reasons, thyroidectomy was indicated
because of esophageal or tracheal com-
pression caused by thyroid hyperplasia.
Twenty-four cases of colloid
goiters from 21 female and 3 male pa-
tients (mean age: 46.7) with normal
thyroid function were studied and
compared to 12 normal thyroids ob-
tained from necropsies of 9 female and
3 male patients (mean age: 60.1).
Thyroid examination. Tissue frag-
ments were fixed in formalin 3.7%, and
samples obtained from 6 different ar-
eas of the goiters, measuring one
square centimeter, were embedded in
paraffin, cut at 4 mm, and stained with
hematoxylin-eosin (HE). In 6 different
areas from normal thyroids, one region
of the inferior, medium and superior
thirds of each lobe was also examined.
Immunohistochemistry. The anti-
calcitonin monoclonal antibody
(M3509), diluted at 1:1500, was uti-
lized. Tissue sections were deparaffini-
zed and hydrated before a pretreat-
ment with a buffer solution of sodium
citrate 0.01 M, pH 6.0, in a microwave
oven, during 2 cycles of 9 minutes at
900 W. In each cycle, the volume was
completed with the buffer solution to
avoid tissue dryness. Next, the sections
were rinsed in current water, washed in
3% oxygen peroxide solution for 15
minutes, rinsed again in current water,
and then maintained in a phosphate
buffer solution (PBS), pH 7.4, for 10
minutes. In sequence, sections were in-
cubated with the primary antibody for
22 hours at 4°C, before utilizing the
detection system with avidin-biotin
(KO 675). The revelation was per-
formed using the chromogen 3-amine-
9-ethyl-carbazole (AEC A-5754,
Sigma), and Mayer’s hematoxylin was
used in the counterstaining of the sec-
tions. Fragments of a thyroid medullar
carcinoma from an adult patient were
utilized as positive controls, while
negative controls were samples of each
case to be evaluated, without using the
primary antibody.
Cell counting. Areas of one square
centimeter from sections prepared for
histochemistry study were observed
through 100X magnification. C-cells
were counted in 6 different areas, tak-
ing in account the coloration (red-
dened by chromogen AEC), morphol-
ogy, and topography. In each case, the
number of follicles per area was also
counted. The density of C-cells was
determined for each patient, relating
the number of cells observed among
all sections per unit of thyroid tissue
area, expressed as number of cells per
square centimeter. A single observer
determined the mean number of C-
cells per field. Thyroid samples show-
ing adenomatous hyperplasia, edema,
hemorrhage, or fibrosis were not in-
cluded in the present study.
Statistical analysis. The analysis
of variance (Mann-Whitney test)
showed no significant difference in
number of follicles per area (p = 0.40)
between the group of patients with
colloid goiter and normal controls.
Therefore, the analysis was performed
considering the number of C-cells in
6 areas for each patient with colloid
goiter and normal thyroid. The suppo-
sition of normality of the data and
variance homogeneity were verified
through the tests of Kolmogorov-
Smirnov and Bartlett, respectively18.
The Mann-Whitney test was applied
to compare the groups with respect to
the number of C-cells. The signifi-
cance level considered was a = 0.05.
RESULTS
C-cells counted in sections of col-
loid goiters, labeled with anticalcitonin
antibody, showed their presence in
numbers ranging from 1.16 to 23 per
field (one square centimeter) in 15 cases
(62.5%) and were absent in 6 different
areas (one square centimeter) in 9 cases
(37.5%) as shown in table 1.
Table 1 - Frequency of C-cells in
samples from 24 colloid goiters.
Case no. C-cells / 1 square
centimeter
1 21
2 11
3 0
4 1.16
5 5.25
6 0
7 0
8 3.5
9 5.66
10 14
11 8
12 0
13 7.5
14 21.5
15 10.33
16 0
17 0
18 3
19 0
20 7
21 23
22 0
23 18
24 0
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C-cells were observed with higher
frequency, 20 to 148 per field, in thy-
roids of normal controls, with a mean
number of 35.2 per field (Table 2). In
these glands, C-cells frequently ap-
peared as small clusters of more than
10 cells, while in cases of colloid
goiter they were isolated and scattered
through the hyperplastic tissue.
The statistical analysis showed a
significant reduction of C-cell number
in colloid goiters when compared to
normal thyroids (p <0.05). As showed
in table 3, C-cell number in the 6 ar-
eas was significantly greater in pa-
tients with normal thyroids (median:
210) than in patients with colloid
goiter (median: 40).
DISCUSSION
Our data confirm the results de-
scribed by Inoue17, showing a reduc-
tion of C-cells in colloid goiters. In
normal thyroids, these cells are pre-
dominantly found in the superior and
medial thirds of thyroid lateral lobes,
and may as appear single cells or as
forming small clusters positioned
intrafollicularly8,9,17. The distribution
of these cells in the gland is variable
from one individual to another and
may change with age6 and gender19.
C-cell hyperplasia has been de-
scribed in association with tumors20,21
and colloid goiters22; however, the in-
volved physiopathologic mechanisms
are not entirely clear. Experimental
studies23 have suggested that hyperse-
cretion of TSH, a common change ob-
served in colloid goiters, can play a
role in C-cell hyperplasia, although
this finding is yet to be confirmed in
humans. Barbot et al.24 suggested that
TSH regulates calciotonin synthesis
similarly to the thyroid hormone regu-
lation. Microscopic studies of thyroids
from patients with goiters and elevated
calcitonin blood levels show C-cell
hyperplasia25; however, the patho-
genesis is still unclear.
Studies of colloid goiters suggest
that thyroid growth factors do not in-
fluence C-cells. This hypothesis is
favored by the absence of C-cells in
nodules of relapsing goiters, in which
the tissue proliferation is predomi-
nantly asymmetric, differing from the
homogeneous and regular hyperplasia
of thyroid lobular parenchyma26.
Otherwise, colloid goiter is a con-
dition affecting, more frequently, the
lower portions of the gland, while C-
cells are located mainly in the supe-
rior and medial thirds of thyroid lat-
eral lobes3 7,19. Moreover, since C-cell
hyperplasia is more common in males
and the vast majority of patients with
colloid goiter (CG) are females, this
fact could have a role in the reduced
number of C-cells found in samples
from colloid goiters. However, in this
study there was no statistical difference
in female distribution between CG and
normal control group.
Table 2 - Frequency of C-cells in
samples from 12 normal thyroids.
Case no. C-cells / 1 square
centimeter
1 21.25
2 123
3 148
4 27.5
5 43
6 20
7 51
8 32
9 111
10 28
11 11
12 64
Table 3 - Comparative number of C-cells counted in 1 square centimeter areas
from samples of 24 colloid goiter and 12 normal thyroid patients (Mann-Whitney
test).
Groups Cases Minimum Maximum Mean SD Median U p value
CG 24 0 23.0 6.7 7.7 4.4 10.5 <0.0001
Normal 12 11.0 148.0 56.7 45.7 37.5
CG: colloid goiter group; Normal: control group; SD: standard deviation.
p < 0.0001 (Mann-Whitney test).
Figure 1 - Median comportment of C-cells in the colloid goiter group and normal control.
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RESUMO
LIMA MA e col. - Células c em bócio
colóide. Rev. Hosp. Clín. Fac.
Méd. S. Paulo 58(6):310-314,
2003.
OBJETIVO: Pesquisar, quantita-
tivamente, as células C em bócio
colóide com o propósito de investigar
a relação destas células na patogênese
do bócio.
MÉTODO: Foram analisadas 35
tiróides obtidas de tiroidectomia, sen-
do 24 de pacientes com bócio colóide
CONCLUSÕES: Os resultados de-
monstraram redução significativa no
número de células C em bócio colóide
comparando com tiróides normais, in-
dicando que o processo hiperplásico é
restrito às células foliculares em detri-
mento das células C, as quais, prova-
velmente, deixam de receber estímu-
los tróficos e se degeneram.
DESCRITORES: Bócio Colóide.
Células C. Calcitonina. Tiróide.
e 11 tiróides normais de adulto usadas
como controle. Seis diferentes áreas
foram amostradas em média e coradas
com o anticorpo monoclonal antical-
citonina. As células C foram contadas
em campos de 1 cm2 e o número mé-
dio de células/campo foi calculado. Os
dados foram estudados estatisticamen-
te pelo teste de Kruskal-Wallis.
RESULTADOS: O número de cé-
lulas C variou de 0 a 23/cm2 em bócio
colóide e em tiróides normais de 20 a
148/cm2.
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